Search

Susan Nmn Ungar

Examiner (ID: 13594)

Most Active Art Unit
1642
Art Unit(s)
2899, 1642, 1806
Total Applications
662
Issued Applications
234
Pending Applications
203
Abandoned Applications
225

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 923039 [patent_doc_number] => 07319011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)' [patent_app_type] => utility [patent_app_number] => 11/100640 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10957 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319011.pdf [firstpage_image] =>[orig_patent_app_number] => 11100640 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/100640
Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC) Apr 6, 2005 Issued
Array ( [id] => 7121996 [patent_doc_number] => 20050013825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Vaccine containing the catalytic subunit of telomerase for treating cancer' [patent_app_type] => utility [patent_app_number] => 10/877146 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 104 [patent_figures_cnt] => 104 [patent_no_of_words] => 103028 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10877146 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/877146
Vaccine containing the catalytic subunit of telomerase for treating cancer Jun 23, 2004 Abandoned
Array ( [id] => 7082688 [patent_doc_number] => 20050048068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Therapeutic compounds for ovarian cancer' [patent_app_type] => utility [patent_app_number] => 10/813859 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19390 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048068.pdf [firstpage_image] =>[orig_patent_app_number] => 10813859 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/813859
Therapeutic compounds for ovarian cancer Mar 30, 2004 Abandoned
Array ( [id] => 7024937 [patent_doc_number] => 20050019331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Synthetic peptide neutrophil cell chemotactic agents' [patent_app_type] => utility [patent_app_number] => 10/718930 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4697 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019331.pdf [firstpage_image] =>[orig_patent_app_number] => 10718930 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/718930
Synthetic peptide neutrophil cell chemotactic agents Nov 19, 2003 Abandoned
Array ( [id] => 7289340 [patent_doc_number] => 20040110219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Methods for diagnosis and therapy of pancreatic cancer and composition useful therein' [patent_app_type] => new [patent_app_number] => 10/696487 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6113 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110219.pdf [firstpage_image] =>[orig_patent_app_number] => 10696487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/696487
Methods for diagnosis and therapy of pancreatic cancer and composition useful therein Oct 28, 2003 Issued
Array ( [id] => 7199054 [patent_doc_number] => 20040086455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Detection and treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/688464 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10442 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086455.pdf [firstpage_image] =>[orig_patent_app_number] => 10688464 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/688464
Detection and treatment of cancer Oct 16, 2003 Abandoned
Array ( [id] => 6905604 [patent_doc_number] => 20050100999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Nucleic acid encoding receptor type protein kinase' [patent_app_type] => utility [patent_app_number] => 10/653147 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6878 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100999.pdf [firstpage_image] =>[orig_patent_app_number] => 10653147 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/653147
Nucleic acid encoding receptor type protein kinase Sep 2, 2003 Abandoned
Array ( [id] => 7083114 [patent_doc_number] => 20050048494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Colorectal cancer prognostics' [patent_app_type] => utility [patent_app_number] => 10/651237 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7951 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048494.pdf [firstpage_image] =>[orig_patent_app_number] => 10651237 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/651237
Colorectal cancer prognostics Aug 26, 2003 Abandoned
10/332923 Method of detecting an increased susceptibility to breast cancer May 14, 2003 Abandoned
Array ( [id] => 7289405 [patent_doc_number] => 20040110239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Detection to the HER2 receptor by means of biotinilated humanized antibody' [patent_app_type] => new [patent_app_number] => 10/417336 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4175 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110239.pdf [firstpage_image] =>[orig_patent_app_number] => 10417336 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/417336
Detection to the HER2 receptor by means of biotinilated humanized antibody Apr 16, 2003 Abandoned
Array ( [id] => 6769921 [patent_doc_number] => 20030215861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Methods of treating a BRCA associated disorder' [patent_app_type] => new [patent_app_number] => 10/410207 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5627 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215861.pdf [firstpage_image] =>[orig_patent_app_number] => 10410207 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/410207
Methods of treating a BRCA associated disorder Apr 9, 2003 Abandoned
Array ( [id] => 7429009 [patent_doc_number] => 20040001789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof' [patent_app_type] => new [patent_app_number] => 10/403516 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8148 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001789.pdf [firstpage_image] =>[orig_patent_app_number] => 10403516 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/403516
Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof Mar 30, 2003 Abandoned
Array ( [id] => 7467539 [patent_doc_number] => 20040053830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'BCMP84 protein, compositions, diagnostic and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 10/382478 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38403 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053830.pdf [firstpage_image] =>[orig_patent_app_number] => 10382478 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/382478
BCMP84 protein, compositions, diagnostic and therapeutic uses thereof Mar 5, 2003 Abandoned
Array ( [id] => 7364835 [patent_doc_number] => 20040005644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Method and composition for detection and treatment of breast cancer' [patent_app_type] => new [patent_app_number] => 10/373801 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29841 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005644.pdf [firstpage_image] =>[orig_patent_app_number] => 10373801 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/373801
Method and composition for detection and treatment of breast cancer Feb 26, 2003 Abandoned
Array ( [id] => 6804662 [patent_doc_number] => 20030232056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Compositions and methods for the therapy and diagnosis of ovarian cancer' [patent_app_type] => new [patent_app_number] => 10/369186 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46416 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232056.pdf [firstpage_image] =>[orig_patent_app_number] => 10369186 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/369186
Compositions and methods for the therapy and diagnosis of ovarian cancer Feb 13, 2003 Abandoned
Array ( [id] => 6769954 [patent_doc_number] => 20030215894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Protein-induced monoclonal receptors to protein ligands' [patent_app_type] => new [patent_app_number] => 10/350405 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 36814 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215894.pdf [firstpage_image] =>[orig_patent_app_number] => 10350405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/350405
Protein-induced monoclonal receptors to protein ligands Jan 23, 2003 Abandoned
Array ( [id] => 6739716 [patent_doc_number] => 20030157085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Antitumor agents' [patent_app_type] => new [patent_app_number] => 10/314439 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4526 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157085.pdf [firstpage_image] =>[orig_patent_app_number] => 10314439 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/314439
Antitumor agents Dec 8, 2002 Abandoned
Array ( [id] => 6851445 [patent_doc_number] => 20030143648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Enzyme activity profiles' [patent_app_type] => new [patent_app_number] => 10/304559 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 13145 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143648.pdf [firstpage_image] =>[orig_patent_app_number] => 10304559 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/304559
Enzyme activity profiles Nov 24, 2002 Abandoned
Array ( [id] => 7395719 [patent_doc_number] => 20040022785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth' [patent_app_type] => new [patent_app_number] => 10/302663 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26201 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022785.pdf [firstpage_image] =>[orig_patent_app_number] => 10302663 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/302663
Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth Nov 21, 2002 Abandoned
Array ( [id] => 7329741 [patent_doc_number] => 20040254101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Colon specific gene and protein and cancer' [patent_app_type] => new [patent_app_number] => 10/291773 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 79201 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254101.pdf [firstpage_image] =>[orig_patent_app_number] => 10291773 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/291773
Colon specific gene and protein and cancer Nov 11, 2002 Abandoned
Menu